Table 1. Study population and reference test results.
Control | HAT | p-value | |||
n/N | n/N | ||||
% male | 53/117 | 45% | 53/117 | 45% | |
Median age (IQR) | 117 | 28 (19–41) | 117 | 28 (20–42) | |
Anti-malaria drugs (CI) | 20/116 | 17.2% (10.3–24.2) | 36/112 | 32.1% (23.3–40.9) | 0.01 |
Thick blood film positive | 13/112 | 11.6% (5.6–17.6) | 9/111 | 8.1% (3.0–13.3) | 0.5 |
Median Plasmodium density/µl in positive thick blood film (IQR) | 10/13 | 59 (15–143) | 6/9 | 109 (52–296) | |
Malaria PCR positive | 44/117 | 37.6% (28.7–46.5) | 35/116 | 30.2% (21.7–38.7) | 0.4 |
Pf-PCR positive | 38/117 | 32.5% (23.9–41.1) | 31/116 | 26.7% (18.6–34.9) | 0.3 |
IQR: interquartile range, CI: confidence interval.